Related Experiment Video
Updated: Aug 29, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Structural Limitations of Early-Late Treatment Comparisons Under Target Trial Emulation: A Simulation Study
Atsushi Takayama1, Shiro Tanaka2, Koji Kawakami1
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Abstract:
Early versus Late (E-L) treatment initiation comparisons, which are prone to immortal time bias, are widely considered amenable to causal inference through target trial emulation (TTE) using clone-censor-weighting (CCW). However, whether standard CCW yields a well-defined causal estimand for the E-L comparison under ideal implementation conditions has not been formally examined. We conducted a structural simulation study to evaluate CCW-based TTE for E-L comparisons. The design varied along three dimensions: treatment-initiation mechanisms (random versus baseline-confounded timing), benefit-harm structures governing delayed-treatment harm and post-treatment benefit, and five distinct E-L initiation-window configurations. We implemented CCW as conventionally recommended and summarized estimated 12-month marginal risk ratios across settings. Depending on the placement and structure of the initiation windows, estimated risk ratios exhibited systematic window-dependent variation, including direction reversals across window specifications, even in settings where the true marginal causal contrast was 1 by design. These patterns were not consistently explained by weight instability or lack of support overlap. Our findings indicate that, in E-L comparisons, the window-defined strategy contrast estimated using CCW-based TTE can be strongly shaped by risk accumulated before treatment initiation under the specified windows, underscoring the need for caution when interpreting E-L analyses.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Comparing the Survival Analysis of Two or More Groups
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence of Drugs: Drugs with Multiple Indications